158 related articles for article (PubMed ID: 18621428)
1. Long-term results of a prospective multicenter phase II study to preserve the larynx function using concomitant boost radiochemotherapy with Carboplatin.
Rudat V; Eckel H; Volling P; Schröder M; Staar S; Wallner F; Wannenmacher M; Dietz A
Radiother Oncol; 2008 Oct; 89(1):33-7. PubMed ID: 18621428
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
[TBL] [Abstract][Full Text] [Related]
3. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
Racadot S; Mercier M; Dussart S; Dessard-Diana B; Bensadoun RJ; Martin M; Malaurie E; Favrel V; Housset M; Durdux C; Journel C; Calais G; Huet J; Pillet G; Hennequin C; Haddad E; Diana C; Blaska-Jaulerry B; Henry-Amar M; Géhanno P; Baillet F; Mazeron JJ
Radiother Oncol; 2008 May; 87(2):164-72. PubMed ID: 18222010
[TBL] [Abstract][Full Text] [Related]
6. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
Lambert L; Fortin B; Soulières D; Guertin L; Coulombe G; Charpentier D; Tabet JC; Bélair M; Khaouam N; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):398-402. PubMed ID: 19394155
[TBL] [Abstract][Full Text] [Related]
7. Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.
Liberman PH; Schultz C; Gomez MV; Carvalho AL; Pellizzon AC; Testa JR; Feher O; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1265-8. PubMed ID: 15545579
[TBL] [Abstract][Full Text] [Related]
8. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
10. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M
Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123
[TBL] [Abstract][Full Text] [Related]
12. Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancer.
Corry J; Rischin D; Cotton S; D'Costa I; Chua M; Vallance N; Lyons B; Kleid S; Sizeland A; Peters LJ
J Med Imaging Radiat Oncol; 2011 Apr; 55(2):229-35. PubMed ID: 21501415
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
[TBL] [Abstract][Full Text] [Related]
16. Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
Eckardt A; Sinikovic B; Hofele C; Bremer M; Reuter C
Oncology; 2007; 73(3-4):198-203. PubMed ID: 18424883
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx who received concurrent chemoradiation therapy with carboplatin (CBDCA) - AUC 1.5 vs AUC 2.0.
Furusaka T; Matsuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 Nov; 132(11):1215-23. PubMed ID: 23025385
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation.
Featherstone CJ; Clarke S; Jackson MA; Shannon KF; McNeil EB; Tin MM; Clifford A; O'Brien CJ
ANZ J Surg; 2004 Jul; 74(7):554-8. PubMed ID: 15230789
[TBL] [Abstract][Full Text] [Related]
19. Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus.
Rabbani A; Amdur RJ; Mancuso AA; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):351-5. PubMed ID: 18395359
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]